Fig. 2
From: The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
Production protocols for naturally circulating dendritic cells. Schematic overview of the (a) CD1c+ myeloid dendritic cell (mDC) and (b) plasmacytoid dendritic cell (pDC) production protocols and vaccination strategy of the various clinical trials